Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Neuromuscular Disorders

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0960-8966(92)90059-FPMID 1483053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apparent association of mental retardation and specific patterns of deletions screened with probes cf56a and cf23a in Duchenne muscular dystrophy.

  1991cited by this paper
• Molecular deletion patterns in families from southern France with Duchenne/Becker muscular dystrophies

  1991cited by this paper
• A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods.

  1991cited by this paper
• Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

  1991cited by this paper
• Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes.

  1991cited by this paper
• Intragenic deletions in 164 boys with Duchenne muscular dystrophy (DMD) studied with dystrophin cDNA

  1990cited by this paper
• Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies.

  1990cited by this paper
• Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction

  1990cited by this paper
• Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility.

  1990cited by this paper
• Becker muscular dystrophy: correlation of deletion type with clinical severity.

  1990cited by this paper
• Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene.

  1989cited by this paper
• The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

  1989cited by this paper
• An efficient salt-chloroform extraction of DNA from blood and tissues.

  1989cited by this paper
• Dystrophin abnormalities in Duchenne/Becker muscular dystrophy.

  1989cited by this paper
• Analysis of molecular deletions with cDNA probes in patients with Duchenne and Becker muscular dystrophies.

  1989cited by this paper
• Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.

  1989cited by this paper
• Gene deletions in X-linked muscular dystrophy.

  1989cited by this paper
• Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy.

  1989cited by this paper
• Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy.

  1988cited by this paper
• Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.

  1988cited by this paper
• An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

  1988cited by this paper
• Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain

  1988cited by this paper
• Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

  1987cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper
• Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion.

  1985cited by this paper
• Implications of diagnostic delay in Duchenne muscular dystrophy.

  1983cited by this paper
• Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome.

  1983cited by this paper
• Intellect and Behaviour in Duchenne Muscular Dystrophy

  1981cited by this paper
• X‐Linked muscular dystrophy

  1977cited by this paper
• Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

  1977cited by this paper
• Clinical studies in benign (Becker type) X‐linked muscular dystrophy

  1976cited by this paper

• Intellectual disability and genotype-phenotype correlation between full-scale intelligence quotient and mutation characteristics in boys with dystrophinopathy.

  2025cites this paper
• Brain Matters in Duchenne Muscular Dystrophy: DMD Mutation Sites and Their Association with Neurological Comorbidities Through Isoform Impairment

  2025cites this paper
• Dystrophin genetic variants and autism

  2022cites this paper
• COGNITIVE PROFILE AND NEUROPSYCHIATRIC DISORDERS IN BECKER MUSCULAR DYSTROPHY: A SYSTEMATIC REVIEW OF LITERATURE.

  2022cites this paper
• A rare case of monozygotic triplets with Duchenne Muscular Dystrophy.

  2021cites this paper
• The impact of genotype on outcomes in individuals with Duchenne muscular dystrophy: A systematic review

  2021cites this paper
• Towards Central Nervous System Involvement in Adults with Hereditary Myopathies

  2020cites this paper
• Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy

  2020cites this paper
• Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy

  2019cites this paper
• Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment?

  2018cites this paper
• Neurobiologie des troubles cognitifs des modèles murins de la myopathie de Duchenne

  2017cites this paper
• The Therapeutic Implications of Muscular Dystrophy Genomics

  2017cites this paper
• Non-deletion mutations in Egyptian patients with Duchenne muscular dystrophy

  2014cites this paper
• Clinical, immunohistochemical, Western blot, and genetic analysis in dystrophinopathy.

  2013cites this paper
• Genetic diagnosis prevention and molecular pathophysiology of duchenne muscular dystrophy and non invasive diagnosis of familial neuromuscular disorders

  2013cites this paper
• Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation.

  2012cites this paper
• Reading difficulties in duchenne muscle dystrophy patients : basis of verbal working memory in cerebellar circuits

  2011cites this paper
• [Numeric alterations in the dys gene and their association with clinical features].

  2011cites this paper
• Dystrophin Dp71: The Smallest but Multifunctional Product of the Duchenne Muscular Dystrophy Gene

  2011cites this paper
• Genotype-Phenotype Correlation among patients with Dystrophinopathies

  2010cites this paper
• Dystrophin Gene Mutation Location and the Risk of Cognitive Impairment in Duchenne Muscular Dystrophy

  2010cites this paper
• Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.

  2009cites this paper
• Duchenne muscular dystrophy: a clinical, histopathological and genetic study at a neurology tertiary care center in Southern India.

  2009cites this paper
• Anticipatory postural adjustments in a bimanual load-lifting task in children with Duchenne muscular dystrophy.

  2006cites this paper
• Mental Retardation

  2005cites this paper
• Analysis of Dystrophin Gene Deletions Indicates that the Hinge III Region of the Protein Correlates with Disease Severity

  2005cites this paper
• Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity.

  2005cites this paper
• Duchenne And Becker Muscular Dystrophies

  2005cites this paper
• Association of Duchenne Muscular Dystrophy With Autism Spectrum Disorder

  2005cites this paper
• Clinical, Immunohistochemical, and Genetic Analysis in Dystrophinopathy

  2004cites this paper
• DUCHENNE PHENOTYPE WITH MAJOR PORTION OF DYSTROPHIN ROD: THRESHOLD EFFECT FOR DELETION SIZE? IN-FRAME DELETION REMOVING

  2004cites this paper
• Dystrophin and mutations: one gene, several proteins, multiple phenotypes.

  2003cites this paper
• β-Dystrobrevin interacts directly with kinesin heavy chain in brain

  2003influential citation
• Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.

  2003cites this paper
• Genital ulcers, stigma, HIV, and STI control in sub-Saharan Africa

  2002cites this paper
• Increased Vulnerability of Auditory System to Noise Exposure in mdx Mice

  2002cites this paper
• The dystrophin–glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies

  2001cites this paper
• Brain dystrophin, neurogenetics and mental retardation.

  2000cites this paper
• Severe cognitive impairment in DMD: obvious clinical evidence for Dp71 isoform point mutations screening

  2000cites this paper
• Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening.

  2000cites this paper
• Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy

  2000cites this paper
• Blood loss in Duchenne muscular dystrophy: vascular smooth muscle dysfunction?

  1999cites this paper
• Duchenne and Becker muscular dystrophies: an Estonian experience.

  1999influential citation
• A novel deletion of the dystrophin S-promoter region cosegregating with mental retardation

  1999cites this paper
• Utilization of unconventional treatments by persons with MS: Is it alternative or complementary?

  1999cites this paper
• Molecular characterisation of Duchenne muscular dystrophy and phenotypic correlation.

  1998cites this paper
• Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy?

  1998cites this paper
• Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy

  1998cites this paper
• A splice variant of Dp71 lacking the syntrophin binding site is expressed in early stages of human neural development.

  1997cites this paper
• Correlation of laboratory and clinical findings with the location of Xp21 deletion in Duchenne muscular dystrophy.

  1997cites this paper
• Extra-muscle involvement in dystrophinopathies: an electroretinography and evoked potential study.

  1997cites this paper
• Epilepsy in Duchenne and Becker muscular dystrophies.

  1997cites this paper
• Muscular dystrophy, mental retardation and cardiomyopathy not associated with dystrophin deficiency.

  1996cites this paper
• An in vivo and in vitro 1H-magnetic resonance spectroscopy study of mdx mouse brain: Abnormal development or neural necrosis?

  1996cites this paper
• Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy.

  1996cites this paper
• Molecular forms of acetyl‐ and butyrylcholinesterase in normal and dystrophic mouse brain

  1996cites this paper
• Duchenne phenotype with in‐frame deletion removing major portion of dystrophin rod: Threshold effect for deletion size?

  1996cites this paper
• DELETION STATUS AND INTELLECTUAL IMPAIRMENT IN DUCHENNE MUSCULAR DYSTROPHY

  1995cites this paper
• Brain abnormalities in Duchenne muscular dystrophy: phosphorus-31 magnetic resonance spectroscopy and neuropsychological study.

  1995cites this paper
• Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.

  1994cites this paper
• Deletions in the 5' region of dystrophin and resulting phenotypes.

  1994cites this paper
• Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.

  1994cites this paper
• Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients.

  1993cites this paper
• Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

  1993cites this paper
• The muscular dystrophies and dystrophin

  1993cites this paper
• Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.

  1993cites this paper